Compass Biotechnologies Inc. (OTC:COBI)
Industry: Financial

OFF LIST - 1157 consecutive market days: OFF LIST as of 10/28/2011 Through 11/14/2016

Compass Biotechnologies Inc., a development stage biotechnology company, develops licenses for patents pertaining to the technology utilized in the prevention and treatment of hepatitis C. It focuses on the development and commercialization of generic, biosimiliar, and biobetter drugs. The company was formerly known as Cyplasin Biomedical, Ltd. and changed its name to Compass Biotechnologies Inc. in March 2011. Compass Biotechnologies Inc. was incorporated in 2004 and is based in Lake Mary, Florida.

Current Quote*
Last: $0.000
Change: 0.000
Book: $Unk
Volume: 21,054,147

As Of: 11/16 15:50 ET
*Quotes delayed by 20min.

Graphs for COBI

3 Month Graph

6 Month Graph

1 Year Graph